[{"uuid": "62191e40-a2ab-3e1f-8b6f-f478199d92df", "title": "Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/strong-sales-growth-cresemba-zevtera-061500934.html", "providerPublishTime": 1738044900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VnkXMaenzioAFn9JFhD_KA--~B/aD05NzA7dz0yODQzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ab6630399880cc3ea968f1a9f177a73c", "width": 2843, "height": 970, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Jfefn4KZ6zu8zJQ_ScIqzQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ab6630399880cc3ea968f1a9f177a73c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMUF"]}, {"uuid": "cd8febe6-1399-3486-818b-00e6ab7799b1", "title": "Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-highlight-2025-strategic-120000375.html", "providerPublishTime": 1736769600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "eeae5b8f-5a14-3f03-88e4-9938fc4d0a3c", "title": "Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-present-43rd-annual-120000951.html", "providerPublishTime": 1736337600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "b656e148-a91a-3473-a5e0-2759cfae09e0", "title": "Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-retains-financial-advisor-100000541.html", "providerPublishTime": 1734343200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "580e6b46-e0a3-3774-b676-3a7ddca0beb9", "title": "Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/concerned-shareholder-group-calls-atea-220500741.html", "providerPublishTime": 1734559500, "type": "STORY"}, {"uuid": "e80f412c-0969-384b-b6e9-7c46be03c885", "title": "Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-announces-results-phase-120651791.html", "providerPublishTime": 1733400411, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CelDdPDqWVkcG2SiBC__kg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c4f6c07e08d4829fbea65fa26099a197", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JPH2pCpc9DwVOqszBsURww--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/c4f6c07e08d4829fbea65fa26099a197", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "4f3c8c6e-1672-37b9-b6d8-532ed66e2a26", "title": "US Penny Stocks To Watch In December 2024", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/us-penny-stocks-watch-december-170735022.html", "providerPublishTime": 1735060055, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ZDGE", "AVIR", "IFRX"]}, {"uuid": "1909ab18-f07e-3bcf-84fa-6b41843b34d1", "title": "Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-avir-stock-outpacing-144011099.html", "providerPublishTime": 1732286411, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/AwCmIhR0z9Bg4cEkwuNQjw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/n4.AbgyuCxTPgpWcYEizKw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR", "BFLY-WS"]}, {"uuid": "bc9bb007-874e-3a1c-9fe8-3555f5529337", "title": "Atea Pharmaceuticals Announces Positive Results from Phase 2 Study of Bemnifosbuvir and Ruzasvir Regimen for Treatment of Hepatitis C Virus (HCV)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-announces-positive-results-120000112.html", "providerPublishTime": 1733313600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "0b754b8d-8449-31a8-98c7-46ab9b5f7898", "title": "Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-reports-third-quarter-210500949.html", "providerPublishTime": 1731013500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "d4527ea6-d36d-3ef0-bdd3-f71532091090", "title": "Atea Pharmaceuticals to Present and Provide a Business Update at the 7th Annual Evercore HealthCONx Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-present-business-7th-120000692.html", "providerPublishTime": 1732622400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}, {"uuid": "a62e000c-8d77-30e3-b67a-a527d667310e", "title": "Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD\u2019s The Liver Meeting 2024", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/atea-pharmaceuticals-presents-multiple-datasets-160000655.html", "providerPublishTime": 1731686400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 904, "height": 513, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XAy3S.w54ZQJLsBzUDWVFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AVIR"]}]